The latest technological advance in the field of fractional lasers is demonstrated in a novel fractional device: Affirm with Multiplex technology (Cynosure, Westford, Massachusetts), a combination Nd:YAG laser emitting 1320- and 1440-nm wavelengths in sequential 3-millisecond pulses composed of 1000 microbeams per 10-mm spot. The 1440-nm wavelength exerts a resurfacing effect and acts more superficially, targeting rhytids and pigmentation. The 1320-nm wavelength targets deeper tissues, stimulating neocollagenesis and thereby improving skin laxity.
Reappearance of fractional laser–induced treatment zone erythema following a hot shower. A, Appearance of normal forearm skin prior to treatment. Appearance of treatment areas after 5 minutes (B), 30 minutes (C), 48 hours (D), and 48 hours after a hot shower (E). Arrows indicate nevi. Fluences of the corresponding wavelengths of the combination fractional laser device are provided. Although these results were obtained from a time course experiment in which forced air and direct cooling were not used, the recall phenomenon occurs in the presence or absence of cooling (data not shown).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination
A 25-year-old man was a restrained passenger in a high-speedmotor vehicle collision. He reports...
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.